Jose P. López-Atalaya Martínez
Biography
|
Jose Pascual López-Atalaya Martínez is a Tenured Scientist (Científico Titular) of the CSIC and leader of the Cellular plasticity and neuropathology group at the Instituto de Neurociencias (IN, CSIC-UMH), within the scientific programme "Cell plasticity in brain disease and repair". The goal of our lab is to understand how brain’s innate immune cells integrate within neural circuits to influence brain function in health and disease. The questions we pursue are grounded in understanding the interplay between brain physiology and the brain’s innate immune system, as a central axis controlling homeostasis and disease. Our research is focused in two lines: (1) Understanding integrated brain circuits: we aim to elucidate the roles of neuron-microglia interactions at multiple levels, from synapses to neural circuits, in the control of brain function in health and disease. (2) Investigating cellular plasticity of immune cells of the brain: the ability of innate immune cells of the brain to adopt alternative fates when exposed to different conditions is now emerging as an important process in normal physiology and in disease conditions, such as aging and neurodegenerative diseases. We seek to understand how microglia cells interpret cues from their tissue microenvironment to adopt specialized roles. We have particular interest in unveiling the molecular mechanisms regulating the transitions and maintenance of distinct phenotypic and functional states of brain’s innate immune cells. (Description curated from publicly available data.) |
Profile
| Institution | IN |
| Position | Tenured Scientist (Científico Titular CSIC), Group leader |
| Home page | https://in.umh-csic.es/en/author/jose-lopez/ |
| Contact email | jose.lopezatalaya@csic.es |
| ORCID | 0000-0001-6064-7584 |
BCB Hub
| BCB Committee | Not a member |
| BCB Tools | |
| BCB Services |
Research
Research topics
Research lines
Projects, networks, transfer & teaching
Funded projects 1
Publications 50 entries
- Sex-dependent interferon signaling contributes to female-biased vulnerability in Alzheimer’s disease Article · 4 May 2026
- Multiscale Approximations to Understand the Complex Role of Microglia in Alzheimer's Disease Article · May 2026
- MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders Article · 24 Mar 2026
- Whole transcriptome analysis of peripheral blood mononuclear cells from de novo and drug-naive Parkinson's disease patients Article · Oct 2025
- Early lineage divergence segregates sensory and non-sensory thalamic circuits Preprint · 22 Jul 2025
View all (45 more)
- Type I interferon signalling and interferon‐responsive microglia in health and disease Article · 29 Apr 2025
- Microglial reprogramming enhances antitumor immunity and immunotherapy response in melanoma brain metastases Article · Mar 2025
- Two distinct epithelial-to-mesenchymal transition programs control invasion and inflammation in segregated tumor cell populations Article · 16 Oct 2024
- MICROGLIA REGULATE LEARNING AND MEMORY THROUGH NF-ΚB Article · Oct 2023
- Cell-specific vulnerability to metabolic failure: the crucial role of parvalbumin expressing neurons in creatine transporter deficiency Article · 7 Mar 2023
- CBP and p300 Jointly Maintain Neural Progenitor Viability but Play Unique Roles in the Differentiation of Neural Lineages Article · 18 Dec 2022
- CBP Is Required for Establishing Adaptive Gene Programs in the Adult Mouse Brain Article · 15 Sep 2022
- Transcriptional regulation of chemokine network by biologic monotherapy in ileum of patients with Crohn’s disease Article · Mar 2022
- A protocol to extract cell-type-specific signatures from differentially expressed genes in bulk-tissue RNA-seq Article · Mar 2022
- Secondary loss of miR-3607 reduced cortical progenitor amplification during rodent evolution Article · 14 Jan 2022
- SFRP1 modulates astrocyte-to-microglia crosstalk in acute and chronic neuroinflammation Article · 27 Sep 2021
- Sublayer- and cell-type-specific neurodegenerative transcriptional trajectories in hippocampal sclerosis Article · Jun 2021
- Astrocytes and neurons share region-specific transcriptional signatures that confer regional identity to neuronal reprogramming Article · 9 Apr 2021
- A Zic2-regulated switch in a noncanonical Wnt/βcatenin pathway is essential for the formation of bilateral circuits Article · 13 Nov 2020
- Repression of Irs2 by let‐7 miRNAs is essential for homeostasis of the telencephalic neuroepithelium Article · 28 Sep 2020
- KAT3-dependent acetylation of cell type-specific genes maintains neuronal identity in the adult mouse brain Article · 22 May 2020
- Ecdysone-Induced 3D Chromatin Reorganization Involves Active Enhancers Bound by Pipsqueak and Polycomb Article · Sep 2019
- Cbp-dependent histone acetylation mediates axon regeneration induced by environmental enrichment in rodent spinal cord injury models Article · 10 Apr 2019
- Development and maintenance of the brain's immune toolkit: Microglia and non‐parenchymal brain macrophages Article · 24 Oct 2017
- Loss of Kdm5c Causes Spurious Transcription and Prevents the Fine-Tuning of Activity-Regulated Enhancers in Neurons Article · Oct 2017
- Lack of IL-1R8 in neurons causes hyperactivation of IL-1 receptor pathway and induces MECP2-dependent synaptic defects Article · 28 Mar 2017
- Specific promoter deacetylation of histone H3 is conserved across mouse models of Huntington's disease in the absence of bulk changes Article · May 2016
- Brain size regulations by cbp haploinsufficiency evaluated by in-vivo MRI based volumetry Article · 6 Nov 2015
- Blocking miRNA Biogenesis in Adult Forebrain Neurons Enhances Seizure Susceptibility, Fear Memory, and Food Intake by Increasing Neuronal Responsiveness Article · 16 Jan 2015
- Can changes in histone acetylation contribute to memory formation? Article · Dec 2014
- Epigenetic Factors in Intellectual Disability Book / chapter · 2014
- Histone H3 lysine methylation in cognition and intellectual disability disorders Article · 17 Sep 2013
- Lysine Acetyltransferases CBP and p300 as Therapeutic Targets in Cognitive and Neurodegenerative Disorders Article · 1 Jul 2013
- Genomic targets, and histone acetylation and gene expression profiling of neural HDAC inhibition Article · 1 Jul 2013
- Genomic Landscape of Transcriptional and Epigenetic Dysregulation in Early Onset Polyglutamine Disease Article · 19 Jun 2013
- Histone acetylation deficits in lymphoblastoid cell lines from patients with Rubinstein–Taybi syndrome Article · 7 Oct 2011
- CBP is required for environmental enrichment‐induced neurogenesis and cognitive enhancement Article · 16 Aug 2011
- Syndromic features and mild cognitive impairment in mice with genetic reduction on p300 activity: Differential contribution of p300 and CBP to Rubinstein–Taybi syndrome etiology Article · Jan 2010
- Selective Boosting of Transcriptional and Behavioral Responses to Drugs of Abuse by Histone Deacetylase Inhibition Article · 2 Sep 2009
- Toward Safer Thrombolytic Agents in Stroke: Molecular Requirements for NMDA Receptor-Mediated Neurotoxicity Article · 12 Mar 2008
- Hunting for Synaptic Tagging and Capture in Memory Formation: Figure 1. Article · 21 Nov 2007
- Recombinant Desmodus rotundus Salivary Plasminogen Activator Crosses the Blood–Brain Barrier Through a Low-Density Lipoprotein Receptor-Related Protein-Dependent Mechanism Without Exerting Neurotoxic Effects Article · Mar 2007
- Anti-NR1 N-terminal-domain vaccination unmasks the crucial action of tPA on NMDA-receptor-mediated toxicity and spatial memory Article · 15 Feb 2007
- Tissue‐type plasminogen activator rescues neurones from serum deprivation‐induced apoptosis through a mechanism independent of its proteolytic activity Article · 27 Jun 2006
- The brain-specific tissue-type plasminogen activator inhibitor, neuroserpin, protects neurons against excitotoxicity both in vitro and in vivo Article · Dec 2005
- Tissue-Type Plasminogen Activator Crosses the Intact Blood-Brain Barrier by Low-Density Lipoprotein Receptor–Related Protein-Mediated Transcytosis Article · 3 May 2005
- Arginine 260 of the Amino-terminal Domain of NR1 Subunit Is Critical for Tissue-type Plasminogen Activator-mediated Enhancement of N-Methyl-D-aspartate Receptor Signaling Article · Dec 2004
- 2,7-Bis-(4-Amidinobenzylidene)-Cycloheptan-1-One Dihydrochloride, tPA Stop, Prevents tPA-Enhanced Excitotoxicity Both In Vitro and In Vivo Article · Oct 2004
- Is tissue-type plasminogen activator a neuromodulator? Article · Apr 2004
- Equivocal roles of tissue-type plasminogen activator in stroke-induced injury Article · Mar 2004
